BEAM · ISSUER CIK 1745999
Beam Therapeutics Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 Beam Therapeutics Inc. insiders reported $0.00 of open-market purchases and $1.2M of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.2MInsider selling
−$1.2MNet open-market
Oct 16, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 202620:09 | Oct 16, 2026from Oct 15, 2026 | BEAM | CEO, Director | S · Sell10b5-1 | $23.77 | −50,000 | 1,047,205 | -5% | −$1.2M | ||
| Oct 16, 202620:09 | Oct 16, 2026from Oct 15, 2026 | BEAM | CEO, Director | M · Exercise10b5-1 | $1.03 | +50,000 | 1,072,205 | +5% | $52K | ||
| Oct 2, 202616:05 | Oct 1, 2026 | BEAM | SVP, Finance and Treasurer | S · Sell10b5-1 | $24.41 | −187 | 50,984 | -0% | −$5K | ||
| Sep 25, 202616:05 | Sep 24, 2026 | BEAM | President | G · Gift | — | −123,407 | 130,504 | -49% | — |